Mirum Pharmaceuticals, Inc Mirum (NASDAQ: MIRM) Announces Acquisition of Satiogen Pharmaceuticals Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) confirmed that it has bought Satiogen Pharmaceuticals, Inc. Satiogen, which is now a wholly-owned Mirum subsidiary, was an established LIVMARLI oral solution and volixibat license